Metraipolis › archive › dc_533966626fef

Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the… — Europe PMC PMID:41632305

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41632305
DOI
10.1007/s00262-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-06T04:16:30.651Z
SHA-256 of the archived text
8a6ce9ad2dddeb412fec2e7dea545b0dee634c72370f8999312f283a5925d176
Stable URL of this page
https://metraipolis.com/documento/dc_533966626fef

How to cite

Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the… — Europe PMC PMID:41632305 — Europe PMC (en), https://europepmc.org/article/MED/41632305 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_533966626fef (Metraipolis archive dc_533966626fef, sha256 8a6ce9ad2dddeb412fec2e7dea545b0dee634c72370f8999312f283a5925d176)
BibTeX
@misc{dc533966626fef,
  title = {Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the… — Europe PMC PMID:41632305},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41632305},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_533966626fef; sha256 8a6ce9ad2dddeb412fec2e7dea545b0dee634c72370f8999312f283a5925d176},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41632305. Agents can read the archived copy with the MCP tool read_document.